SCHEMBL2838115

SCHEMBL2838115

Cc1cc(=O)n(CCc2ccccc2)c(-c2ncccc2OCc2ccccc2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASR P41180 4/20 0.55
TSHR P16473 4/20 0.43
ALDH1A1 P00352 3/20 0.43
CYP1A2 P05177 3/20 0.43
CYP2C9 P11712 3/20 0.43
CYP2C19 P33261 3/20 0.43
LMNA P02545 2/20 0.43
CYP3A4 P08684 2/20 0.43
HIF1A Q16665 1/20 0.43
CYP2D6 P10635 2/20 0.43
GRM5 P41594 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
LTA4H P09960 1/20 0.40
MAPK14 Q16539 1/20 0.40
GCK P35557 1/20 0.40
BRD4 O60885 1/20 0.40
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4143491 0.85 CASR (0.67) CASRTSHRALDH1A1CYP1A2CYP2C9
SCHEMBL2837495 0.84 HTR2C (0.41) CASRGRM5LTA4HMAPK14GCK
SCHEMBL2839722 0.81 TSHR (0.46) CASRTSHRALDH1A1CYP1A2CYP2C9
SCHEMBL2839694 0.78 CYP1A2 (0.43) CASRTSHRALDH1A1CYP1A2CYP2C9
SCHEMBL2838847 0.77 CASR (0.55) CASRTSHRALDH1A1CYP1A2CYP2C9
SCHEMBL4151611 0.76 CASR (0.70) CASRTSHRALDH1A1CYP1A2CYP2C9
SCHEMBL4143702 0.76 CASR (0.70) CASRTSHRALDH1A1LMNAMEN1
SCHEMBL2837296 0.76 CASR (0.49) CASRTSHRALDH1A1CYP1A2CYP2C9
SCHEMBL4143102 0.75 CASR (0.51) CASRTSHRALDH1A1CYP1A2CYP2C9
SCHEMBL14535990 0.75 CASR (0.53) CASRTSHRALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010039913-A1 CALCILYTIC COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-04-08 WO disclosed